← Back to Search
Feasibility Of Boron Neutron Capture Therapy (BNCT) For Malignant Pleural Mesothelioma From A Viewpoint Of Dose Distribution Analysis.
M. Suzuki, Y. Sakurai, S. Masunaga, Y. Kinashi, K. Nagata, A. Maruhashi, K. Ono
Published 2006 · Medicine
Download PDFAnalyze on Scholarcy
PURPOSE To investigate the feasibility of boron neutron capture therapy (BNCT) for malignant pleural mesothelioma (MPM) from a viewpoint of dose distribution analysis using Simulation Environment for Radiotherapy Applications (SERA), a currently available BNCT treatment planning system. METHODS AND MATERIALS The BNCT treatment plans were constructed for 3 patients with MPM using the SERA system, with 2 opposed anterior-posterior beams. The (10)B concentrations in the tumor and normal lung in this study were assumed to be 84 and 24 ppm, respectively, and were derived from data observed in clinical trials. The maximum, mean, and minimum doses to the tumors and the normal lung were assessed for each plan. The doses delivered to 5% and 95% of the tumor volume, D(05) and D(95), were adopted as the representative dose for the maximum and minimum dose, respectively. RESULTS When the D(05) to the normal ipsilateral lung was 5 Gy-Eq, the D(95) and mean doses delivered to the normal lung were 2.2-3.6 and 3.5-4.2 Gy-Eq, respectively. The mean doses delivered to the tumors were 22.4-27.2 Gy-Eq. The D(05) and D(95) doses to the tumors were 9.6-15.0 and 31.5-39.5 Gy-Eq, respectively. CONCLUSIONS From a viewpoint of the dose-distribution analysis, BNCT has the possibility to be a promising treatment for MPM patients who are inoperable because of age and other medical illnesses.
This paper references
Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma.
A. Ahamad (2003)
T2* and proton density measurement of normal human lung parenchyma using submillisecond echo time gradient echo magnetic resonance imaging.
H. Hatabu (1999)
The EORTC Boron Neutron Capture Therapy (BNCT) Group: achievements and future projects.
W. Sauerwein (2002)
Long-term Follow-up of Patients with Malignant Pleural Mesothelioma Receiving High-Dose Adenovirus Herpes Simplex Thymidine Kinase/Ganciclovir Suicide Gene Therapy
D. Sterman (2005)
The radiation biology of boron neutron capture therapy.
J. Coderre (1999)
Pharmacokinetics of 10B-p-boronophenylalanine in tumours, skin and blood of melanoma patients: a study of boron neutron capture therapy for malignant melanoma.
H. Fukuda (1999)
Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients.
B. Castagneto (2001)
Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation.
K. Forster (2003)
Trimodality management of malignant pleural mesothelioma.
G. Maggi (2001)
Promising Early Local Control of Malignant Pleural Mesothelioma Following Postoperative Intensity Modulated Radiotherapy (IMRT) to the Chest
A. Ahamad (2003)
Dosimetric study of boron neutron capture therapy with borocaptate sodium (BSH)/lipiodol emulsion (BSH/lipiodol-BNCT) for treatment of multiple liver tumors.
M. Suzuki (2004)
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
R. Barth (2005)
Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model.
Takehiko Murayama (2006)
Neutron Activation of Patients Following Boron Neutron Capture Therapy of Brain Tumors at the High Flux Reactor (HFR) Petten (EORTC Trials 11961 and 11011)
A. Wittig (2005)
Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma
D. Sterman (2005)
Effectiveness of BNCT for recurrent head and neck malignancies.
I. Kato (2004)
Controllability of depth dose distribution for neutron capture therapy at the Heavy Water Neutron Irradiation Facility of Kyoto University Research Reactor.
Y. Sakurai (2002)
Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients.
P. Ruffié (1989)
A preliminary comparative study of two treatment planning systems developed for boron neutron capture therapy: MacNCTPlan and SERA.
C. Wojnecki (2002)
Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.
F. Kong (2006)
Effects of boron neutron capture irradiation on the normal lung of rats.
J. L. Kiger (2004)
The European mesothelioma epidemic
J. Peto (1999)
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
D. Sugarbaker (1999)
Boron concentrations in brain during boron neutron capture therapy: in vivo measurements from the phase I trial EORTC 11961 using a gamma-ray telescope.
W. Verbakel (2003)
Radiation therapy in the management of patients with mesothelioma.
W. Gordon (1982)
This paper is referenced by
Boron Neutron Capture Therapy
K. Ono (2012)
Boron neutron capture therapy for vulvar melanoma and genital extramammary Paget’s disease with curative responses
J. Hiratsuka (2018)
A preliminary experimental study of boron neutron capture therapy for malignant tumors spreading in thoracic cavity.
M. Suzuki (2007)
A novel concept of treatment of diffuse or multiple pleural tumors by boron neutron capture therapy (BNCT).
M. Suzuki (2008)
Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.
S. Altieri (2009)
CURENT ADVANCES AND STRETEGIES FOR REDUCING THE SIDE EFFECTS OF RADIATION THERAPIES USED FOR VARIOUS TYPES OF CANCERS
J. Singh (2012)
Development of thermal neutron flux monitor using small scintillator array coupled with quartz fibers for Boron Neutron Capture Therapy
H. Tanaka (2011)
Reirradiation for locally recurrent lung cancer in the chest wall with boron neutron capture therapy (BNCT)
M. Suzuki (2012)
Development of real-time thermal neutron monitor array for boron neutron capture therapy
Hiroki Tanaka (2018)
Clinical effectiveness of boron neutron capture therapy for a recurrent malignant peripheral nerve sheath tumor in the mediastinum.
M. Inoue (2010)
Characteristics comparison between a cyclotron-based neutron source and KUR-HWNIF for boron neutron capture therapy
H. Tanaka (2009)
Impact of accelerator-based boron neutron capture therapy (AB-BNCT) on the treatment of multiple liver tumors and malignant pleural mesothelioma.
M. Suzuki (2009)
Carboranyl-porphyrazines and derivatives for boron neutron capture therapy: From synthesis to in vitro tests
D. Pietrangeli (2013)
Extending neutron autoradiography technique for boron concentration measurements in hard tissues.
L. Provenzano (2018)
An innovative therapeutic approach for malignant mesothelioma treatment based on the use of Gd/boron multimodal probes for MRI guided BNCT
D. Alberti (2018)
Boron neutron capture therapy in the treatment of lung cancer
Song Chiek Quah (2018)
Boron Chemistry for Medical Applications
F. Ali (2020)
Exploring Boron Neutron Capture Therapy for non-small cell lung cancer.
R. Farías (2014)
Boron uptake measurements in a rat model for Boron Neutron Capture Therapy of lung tumours.
S. Bortolussi (2011)
Understanding the potentiality of accelerator based-boron neutron capture therapy for osteosarcoma: dosimetry assessment based on the reported clinical experience
S. Bortolussi (2017)
Modern Radiotherapy Techniques in Malignant Pleural Mesothelioma
G. Ozyigit (2016)
Research and Development of the Humanitarian Landmine Detection System by a Compact Fusion Neutron Source
K. Yoshikawa (2009)
Optical density analysis in autoradiographic images from BNCT protocols
C. Vidal (2018)
Dosimetric impact of respiratory motion during boron neutron capture therapy for lung cancer
Shaojuan Wu (2020)
Boron neutron capture therapy (BNCT) as a new approach for clear cell sarcoma (CCS) treatment: Trial using a lung metastasis model of CCS.
T. Andoh (2015)
Development of two dimensional thermal neutron flux monitor using multi-wire proportional counter for boron neutron capture therapy
Hiroki Tanaka (2012)
Functional and Histological Changes in Rat Lung after Boron Neutron Capture Therapy
J. L. Kiger (2008)
Toward a clinical application of ex situ boron neutron capture therapy for lung tumors at the RA-3 reactor in Argentina.
R. Farías (2015)
BNCT induced immunomodulatory effects contribute to mammary tumor inhibition
A. A. Khan (2019)
Computational aspects of treatment planning for neutron capture therapy
James Raymond Albritton (2009)
Dosimetry and dose planning in boron neutron capture therapy : Monte Carlo studies
H. Koivunoro (2012)
Research and development of the humanitarian landmine detection system by a compact fusion neutron source
K. Yoshikawa (2007)See more